GON-injection for a sooner and better treatment of cluster headache: a double-blind randomized controlled trial - CHIANTI

eids Universitair Medisch Centrum0 个研究点目标入组 80 人开始时间: 2018年12月20日最近更新: 2019年6月30日

适应症

试验速览

暂无简介。

•- Patients have to be diagnosed with episodic cluster headache according to the international classification of headache disorders – third edition beta, ICHD-3b
•- Patients have to be aged 18-65 years
•- Patients need to be newly diagnosed and treatment naïve, or already diagnosed and currently free from prophylactic treatment
•- Patients need to have a mean of more than 1 attack per day in the 3 days preceding inclusion.
•- Patients should be in their cluster period for shorter than 4 weeks before inclusion.
•Are the trial subjects under 18? no
•Number of subjects for this age range:
•F.1.2 Adults (18-64 years) yes
•F.1.2.1 Number of subjects for this age range 80
•F.1.3 Elderly (>=65 years) no
•F.1.3.1 Number of subjects for this age range

•- A contraindication for treatment with steroids or verapamil
•- The use of anticoagulants or known bleeding disorder.
•- Use of any prophylactic medication for cluster headache
•- Patients with a history of other primary headache who are currently using prophylactic medication for this headache
•- Pregnancy

发起方